Atlas Trials

A Phase Ib/II Study Confirmed Inhibition of Autophagy Synergizes Anti-tumor Effect of High Dose CDK4/6i

Clinical trial NCT05953350 · RECRUITING

Trial details

NCT number
NCT05953350
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Inhibition of Autophagy Synergizes Anti-tumor Effect
Start date
2023-11-07
Primary completion
2024-05-07
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.